Because your skin is always changing, we recommend a Full Body Follow-Up for Year 2 and beyond. We'll compare any changes in your skin and moles against the baseline created during your first appointment.
Who should have a Full Body Follow-Up?
Swipe to see more ⇆
1: You’ve had a Full Body MoleMap previously
If you’ve had a Full Body MoleMap the previous year, a MoleMap follow-up appointment allows us to compare any changes in your skin using the baseline images created.
2: You’re considered high risk
If you’re considered a high-risk patient (take our risk check), we thoroughly recommend a Full Body MoleMap follow-up every year as well as regular spot checks in between.
Swipe to see more ⇆
Why choose MoleMap?
We don’t just check skin. We spot change.
Your skin is always changing. That’s why we combine our proven skin-mapping system with skin cancer expertise to detect the signs of melanoma early – when it’s most treatable.
We spot the spots that you might not.
Melanoma is the most life-threatening of all skin cancers1 and it’s hard to see with an untrained eye. Our advanced dermoscopic technology looks deep inside a mole’s structure to detect skin changes early.
Early detection is your best protection.
Skin cancer can occur at any time and the risk increases as you age.5 On the upside, if it’s detected early, it’s almost always treatable. So don’t leave it to chance: book with MoleMap today.
What’s the MoleMap difference?
The skin cancer specialists.
Our team of leading Dermatologists and Melanographers has been detecting melanoma for over 20 years. It’s all we do, and we do it thoroughly.
We check. And double-check.
The advantage of MoleMap is that not one, but two sets of expert eyes examine any moles of concern: a trained Melanographer and a Dermatologist.
Proven skin-mapping system.
Most skin cancers such as melanoma are difficult to detect with the naked eye. Our proven skin-mapping system is designed to spot skin cancers earlier than visual checks.
Fewer scars. Fewer scares.
Because MoleMap can more accurately identify melanoma, there is less need to surgically remove benign (harmless) moles.6